Skip to main content
. 2021 Mar;22(3):861–869. doi: 10.31557/APJCP.2021.22.3.861

Figure 2.

Figure 2

Expression of CD63, CD81 and CD24 on CD9-Positive Plasma Exosomes of CPPs (A), Stage II CRCPs (B), Stage III CRCPs (C). Isotype control and negative control (latex beads labeled anti-CD9 with anti CD81 FITC antibody) (D). Mean MFI are shown